A series of quinazolin‐4(<scp><i>3H</i></scp>)‐one‐morpholine hybrids as anti‐lung‐cancer agents: Synthesis, molecular docking, molecular dynamics, <scp>ADME</scp> prediction and biological activity studies

Feyzi Sinan Tokalı(Kafkas University), Fahri Akbaş(Bezmiâlem Vakıf Üniversitesi), Halil Şenol, Şeyma Ateşoğlu(Biotechnology Institute)
Chemical Biology & Drug Design
July 1, 2024
10.1111/cbdd.14599
Cited by 39

Related Papers

Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors
|Molecular Diversity|2022|89
Synthesis, characterization, biological activity and molecular docking studies of novel schiff bases derived from thiosemicarbazide: Biochemical and computational approach
|Journal of Molecular Structure|2020|75
Novel acetic acid derivatives containing quinazolin‐4(3<i>H</i>)‐one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors
|Drug Development Research|2023|74
Synthesis, biological evaluation, and in silico study of novel library sulfonates containing quinazolin‐4(<scp>3<i>H</i></scp>)‐one derivatives as potential aldose reductase inhibitors
|Drug Development Research|2021|58
Synthesis and Evaluation of Quinazolin‐4(3 <i>H</i> )‐one Derivatives as Multitarget Metabolic Enzyme Inhibitors: A Biochemistry‐Oriented Drug Design
|ChemistrySelect|2023|54